03/20/2018

Bringing AI to Cardiovascular Disease Research

How one strategic partnership is focusing on methods to better treat cardiovascular disease

Earlier this month, the American Heart Association (AHA) and the Duke Clinical Research Institute announced their partnership to develop and test machine-learning techniques in the research and treatment of cardiovascular disease.

“Together, we will develop new methods and technology for analyzing data, and create abundant opportunities for trainees to excel,” said Jennifer Hall, chief of the AHA’s Institute for Precision Cardiovascular Medicine, in a press release. “We’re pleased to work with the DCRI’s team of data science experts to develop and test emerging strategies to power machine learning.”

AHA’s Institute for Precision Cardiovascular Medicine and DCRI’s science team will use the association’s Precision Medicine Platform—“a cloud-based data resource that revolutionizes how the research community accelerates solutions for cardiovascular diseases and stroke”—to do this work. The platform contains cardiovascular health-related data from DCRI, AstraZeneca, and Intermountain Healthcare, among others.

Please select this link to read the complete article from Associations Now.